Results 251 to 260 of about 1,806,959 (282)
Some of the next articles are maybe not open access.
2014
Multiple sclerosis (MS) is the most common inflammatory, demyelinating, and neurodegenerative disorder of the central nervous system (CNS) in humans. Although the etiology of MS remains unknown, several lines of evidence support the notion that autoimmunity against components of the myelin sheath plays a major role in susceptibility to and development ...
Nicolás, Fissolo +2 more
openaire +2 more sources
Multiple sclerosis (MS) is the most common inflammatory, demyelinating, and neurodegenerative disorder of the central nervous system (CNS) in humans. Although the etiology of MS remains unknown, several lines of evidence support the notion that autoimmunity against components of the myelin sheath plays a major role in susceptibility to and development ...
Nicolás, Fissolo +2 more
openaire +2 more sources
International Journal of Technology Assessment in Health Care, 1994
AbstractIt has been 20 years since the concepts that are now embraced in the term recombinant DNA technology were first described. The technology has been used to design new vaccines, and one product — that for hepatitis B — has been in widespread use for almost a decade.
openaire +2 more sources
AbstractIt has been 20 years since the concepts that are now embraced in the term recombinant DNA technology were first described. The technology has been used to design new vaccines, and one product — that for hepatitis B — has been in widespread use for almost a decade.
openaire +2 more sources
Current Drug Targets - Immune, Endocrine & Metabolic Disorders, 2001
Genes that code for the production of protein antigens have been cloned and recombined with plasmids. Gene-plasmid constructs have been amplified in a bacterial host, purified and administered to a mammalian host. The gene is expressed in the host and the antigen that is produced induces an immune response.
openaire +2 more sources
Genes that code for the production of protein antigens have been cloned and recombined with plasmids. Gene-plasmid constructs have been amplified in a bacterial host, purified and administered to a mammalian host. The gene is expressed in the host and the antigen that is produced induces an immune response.
openaire +2 more sources
2003
Vaccination has relied, in general, on two technologies for the production of antigenic material suitable for the generation of a protective immune response; live infectious agents and inactivated or subunit vaccine preparations. Live infectious agents generally are most efficacious, but there is always a risk factor when using this type of vaccine ...
S, van Drunen Littel-van den Hurk +2 more
openaire +2 more sources
Vaccination has relied, in general, on two technologies for the production of antigenic material suitable for the generation of a protective immune response; live infectious agents and inactivated or subunit vaccine preparations. Live infectious agents generally are most efficacious, but there is always a risk factor when using this type of vaccine ...
S, van Drunen Littel-van den Hurk +2 more
openaire +2 more sources
Methods to improve the immunogenicity of plasmid DNA vaccines
Drug Discovery Today, 2021Ângela Sousa +2 more
exaly
A brief review on DNA vaccines in the era of COVID-19
Future Virology, 2022Massoud Saidijam +2 more
exaly
DNA vaccines against COVID-19: Perspectives and challenges
Life Sciences, 2021Marcelo Mendonça +1 more
exaly
Next-Generation Vaccines: Nanoparticle-Mediated DNA and mRNA Delivery
Advanced Healthcare Materials, 2021Xiaoyang Xu, Mingzhu Gao, Xue-Qing Zhang
exaly
The dangers of DNA vaccination
Nature Medicine, 1999D C, Górecki, J P, Simons
openaire +2 more sources

